共 128 条
[1]
Kaur I. P.(2002)Penetration enhancers and ocular bioadhesives: two new avenues for ophthalmic drug delivery Drug Dev. Ind. Pharm. 28 353-369
[2]
Smitha R.(2006)Drug transport in corneal epithelium and blood–retina barrier: emerging role of transporters in ocular pharmacokinetics Adv. Drug Deliv. Rev. 58 1136-1163
[3]
Mannermaa E.(1998)Acyclovir for recurrent herpes simplex virus ocular disease N. Engl. J. Med. 339 340-341
[4]
Vellonen K. S.(2007)Evidence-based treatment of herpes simplex virus keratitis: a systematic review Ocul. Surf. 5 240-250
[5]
Urtti A.(2000)The treatment of herpes simplex virus epithelial keratitis Trans. Am. Ophthalmol. Soc. 98 505-532
[6]
Jabs D. A.(2004)Comparison of liposome-encapsulated acyclovir with acyclovir ointment: ocular pharmacokinetics in rabbits J Ocul Pharmacol Ther 20 169-177
[7]
Guess S.(2008)Acyclovir therapy in prevention of recurrent herpetic keratitis following penetrating keratoplasty Am. J. Ophthalmol. 145 198-202
[8]
Stone D. U.(2005)Dipeptide monoester ganciclovir prodrugs for treating HSV-1-induced corneal epithelial and stromal keratitis: J. Ocul. Pharmacol. Ther. 21 463-474
[9]
Chodosh J.(1998) and Drugs Today (Barc) 34 241-249
[10]
Wilhelmus K. R.(2002) evaluations J. Infect Dis. 186 S71-S77